The Biosecure Act is a significant legislative proposal aimed at reshaping the pharmaceutical supply chain landscape, particularly concerning the s...
€ 6.6 million investment at Nantong site expands production capabilities for cell culture media Supports local biopharma manufact...
CordenPharma is making a record investment of ~€900m over the next 3 years in expanding its peptide platform, both at its Colorado, US site and in...
Eurofins CDMO Alphora Inc. is excited to announce an expansion of its API capacity and capabilities with the completion of its new API manufacturing faci...
ChargePoint Technology, a leading specialist in powder containment and aseptic transfer solutions, is expanding its presence in India, and announced...
Samsung Bioepis Co., Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for PYZCHIVA&re...
Abzena, the leading end-to-end integrated contract and development manufacturing organization (CDMO) for complex biologics and bioconjugates, andArgonaut...
• Consortium formed between WACKER & CordenPharma has officially entered the pandemic readiness state as of 1 June 2024 to produ...
Partnership to accelerate development of lead product candidate, RO-104; a first-in-class tri-specific biologic for treating neovascular age-relat...
ChargePoint Technology, a powder and liquid transfer specialist, has announced the launch of a new robotic material handling solution aimed at increasing s...
Essential Pharma reaches agreement with AGC Biologics for late phase clinical manufacturing of its immunotherapy candidate for the treatment of high-risk...
Cytiva is addressing industry challenges that hinder patient access and broader adoption of autologous CAR T cell therapies with the launch of the new Se...
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, has launched its M...
AstraZeneca intends to build a $1.5 billion manufacturing facility in Singapore for antibody drug conjugates (ADCs), enhancing global supply of its ADC por...
© 2024 Biopharma Boardroom. All Rights Reserved.
